|
|
|
|
|
|
|
Tg Therapeuticscmn (TGTX)
|
|
14.4 -0.3 (-2.04%)
|
04-20 16:00
|
|
Open:
|
14.7
|
Pre. Close:
|
14.7
|
|
High:
|
14.8
|
Low:
|
14.35
|
|
Volume:
|
630,587
|
Market Cap:
|
1053M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.808 - 14.884
|
14.884 - 14.942
|
|
Low:
|
14.175 - 14.254
|
14.254 - 14.315
|
|
Close:
|
14.276 - 14.407
|
14.407 - 14.508
|
|
|
|
Technical analysis (as of: 2018-04-20 4:34:06 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 17.62  One year: 19.27
|
|
Support:
|
Support1: 12.80 Support2: 10.65
|
|
Resistance:
|
Resistance1:
15.09 Resistance2: 16.50
|
|
Pivot:
|
13.77 
|
|
Moving Averages:
|
MA(5): 14.10 MA(20): 13.97
MA(100): 11.84 MA(250): 11.21
|
|
MACD:
|
MACD(12,26):
-0.09 Signal(12,26,9): -0.16
|
|
%K %D:
|
%K(14,3): 77.78 %D(3): 62.41
|
|
RSI:
|
RSI(14): 52.34
|
|
52-Week:
|
High: 17.35
Low: 7.25 Change(%): 38.5
|
|
Average Vol(K):
|
3-Month: 153462
10-Days 101335
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.TGTX has closed below upper band by 19.9%. Bollinger Bands are 20.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned
2018-04-12T10:22:39-04:00
Verastem: A Solid Player On A Crowded Field
2018-04-09T15:35:18-04:00
Q4 Biotech Catalyst Watchlist: Phase 3 Clinical Trials
2018-03-31T09:11:12-04:00
2 Small Biotechs For The Second Quarter
2018-03-29T23:25:40-04:00
TG Therapeutics (TGTX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
2018-03-20T12:01:06-04:00
Biotechs Approaching New Waters
2018-03-09T16:20:49-05:00
Biotech Forum Daily Digest For March 9th
2018-03-08T07:33:01-05:00
TG Therapeutics misses by $0.02, beats on revenue
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
